HLA-II genes are associated with outcomes of specific immunotherapy for allergic rhinitis
- PMID: 31299142
- DOI: 10.1002/alr.22384
HLA-II genes are associated with outcomes of specific immunotherapy for allergic rhinitis
Abstract
Background: Although the precise mechanisms underlying the efficacy of allergen-specific immunotherapy (AIT) are not clear, some evidence suggests that this may be linked to polymorphisms in HLA-II gene. We aimed to investigate the correlation between HLA-II gene polymorphisms and house dust mite (HDM)-specific immunotherapy efficacy, and evaluate specific polymorphisms as potential biomarkers in allergic rhinitis (AR) patients who would benefit most from AIT.
Methods: Fifty-one Han Chinese patients with AR receiving HDM AIT were recruited. Genomic DNA was extracted from venous blood samples and genotyped for HLA-DRB1 and HAL-DQB1 alleles using the polymerase chain reaction sequence-based genotyping method. Nasal and eye symptoms were investigated based on visual analogue scale and rhinoconjunctivitis quality of life.
Results: Allele DRB1*04:06; DRB1*14:05 showed a positive correlation with improvements in nasal blockage, nasal itching, eye itching, and activities. Similarly, DQB1*03:02:01; DQB1*05:03: 01 was positively correlated with improvements in nose blocking, nasal itching, eye itching, behavioral problems, and nasal symptoms scores; and DRB1*03:01; DRB1*04:06 positively correlated with nasal symptoms scores. In contrast, DRB1*07:01:01; DRB1*11:01 was negatively correlated with non-pollen symptoms, behavioral problems, and nasal symptoms.
Conclusion: HLA-DRB1 and HLA-DQB1 gene polymorphism are associated with AIT efficacy in HDM-sensitive Chinese patients with AR, of which DRB1*03:01; DRB1*04:06 and DQB1*03:02:01; DQB1*05:03:01 may be useful biomarkers of AR patient candidacy for effective AIT.
Keywords: HLA-DQB1; HLA-DRB1; allergen-specific immunotherapy; allergic rhinitis; house dust mites; human leukocyte antigen; polymorphism.
© 2019 ARS-AAOA, LLC.
Similar articles
-
HLA-DRB1*08:03:02 and HLA-DQB1*06:01:01 are associated with house dust mite-sensitive allergic rhinitis in Chinese subjects.Int Forum Allergy Rhinol. 2016 Aug;6(8):854-61. doi: 10.1002/alr.21747. Epub 2016 Mar 25. Int Forum Allergy Rhinol. 2016. PMID: 27013183
-
The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.Int Arch Allergy Immunol. 2016;169(2):113-20. doi: 10.1159/000444391. Epub 2016 Apr 7. Int Arch Allergy Immunol. 2016. PMID: 27049773
-
SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms.Ann Allergy Asthma Immunol. 2015 Feb;114(2):134-40. doi: 10.1016/j.anai.2014.11.015. Ann Allergy Asthma Immunol. 2015. PMID: 25624131 Clinical Trial.
-
An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.J Allergy Clin Immunol. 2013 Dec;132(6):1322-36. doi: 10.1016/j.jaci.2013.09.004. Epub 2013 Oct 18. J Allergy Clin Immunol. 2013. PMID: 24139829 Review.
-
House dust mite sublingual immunotherapy in allergic rhinitis.Immunotherapy. 2018 Jun;10(7):567-578. doi: 10.2217/imt-2018-0013. Epub 2018 Mar 22. Immunotherapy. 2018. PMID: 29562802 Review.
Cited by
-
Analysis of urine differential proteins in patients with allergic rhinitis.Heliyon. 2023 Jun 17;9(6):e17323. doi: 10.1016/j.heliyon.2023.e17323. eCollection 2023 Jun. Heliyon. 2023. PMID: 37426793 Free PMC article.
-
The Association of Human Leukocyte Antigen and COVID-19 in Southern China.Open Forum Infect Dis. 2021 Aug 6;8(9):ofab410. doi: 10.1093/ofid/ofab410. eCollection 2021 Sep. Open Forum Infect Dis. 2021. PMID: 34552996 Free PMC article.
-
Ten-eleven translocation 2 modulates allergic inflammation by 5-hydroxymethylcytosine remodeling of immunologic pathways.Hum Mol Genet. 2021 Oct 13;30(21):1985-1995. doi: 10.1093/hmg/ddab167. Hum Mol Genet. 2021. PMID: 34165552 Free PMC article.
-
Long Non-coding RNAs and mRNAs Expression Profiles of Monocyte-Derived Dendritic Cells From PBMCs in AR.Front Cell Dev Biol. 2021 Feb 9;9:636477. doi: 10.3389/fcell.2021.636477. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33644074 Free PMC article.
References
-
- Zhang L, Han D, Huang D, et al. Prevalence of self-reported allergic rhinitis in eleven major cities in China. Int Arch Allergy Immunol. 2009;149:47-57.
-
- Meltzer EO, Blaiss MS, Naclerio RM, et al. Burden of allergic rhinitis: Allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc. 2012;33(Suppl 1):S113-S141.
-
- Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8-160.
-
- Durham SR, Emminger W, Kapp A, et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol. 2010;125:131-138.e7.
-
- Erekosima N, Suarez-Cuervo C, Ramanathan M, et al. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Laryngoscope. 2014;124:616-627.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
